Mucosis

Mucosis B.V.
Meditech Center
L.J. Zielstraweg 1
9713 GX Groningen
The Netherlands

Trade Register / KvK: 02096219

 

Focus Areas

Mucosis’s efforts are focused on developing vaccines that are administered to the mucosal layers of the nose and mouth, with the intent to raise a strong systemic and local immune reaction that efficiently prevents invasion of pathogens into the body. To achieve this, we have developed a unique formulation technology to re-formulate existing vaccines such that they, for example, can be given to humans with a simple nose spray instead of an intramuscular injection. In addition, we employ our technology to develop new vaccines that address unmet medical needs.